ORLEGI USA, LLC – Trademark Portfolio
Entity Type: 16
ORLEGI USA, LLC holds 14 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 41 (Education & Entertainment) — 14 filings in this category. The portfolio also extends into Class 25 (Clothing) across 4 Nice Classification classes. Currently, 5 trademarks are registered and 9 are pending. Notable registered marks include A, ATLAS, ATLAS FC, and CLUB SANTOS LAGUNA. The owner is based in Houston, TX.
10330 Lake Rd, Suite F 27
Houston, TX 77070
Showing of trademarks Trademarks
Trademark Classifications
ORLEGI USA, LLC's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Education; providing of training; entertainment; sporting and cultural activities
Advertising; business management; business administration; office functions
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does ORLEGI USA, LLC have?
ORLEGI USA, LLC has 14 U.S. trademarks filed with the USPTO. Of these, 5 registered, 9 pending.
What trademark classes does ORLEGI USA, LLC file in?
ORLEGI USA, LLC files trademarks across 4 Nice Classification classes. The most active classes are Class 41 (Education & Entertainment), Class 25 (Clothing), Class 35 (Advertising & Business), Class 9 (Computers & Electronics). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.
What are ORLEGI USA, LLC's most well-known trademarks?
ORLEGI USA, LLC's registered trademark portfolio includes well-known marks such as A, ATLAS, ATLAS FC, and CLUB SANTOS LAGUNA. These are among 5 currently registered trademarks in the portfolio.
What is ORLEGI USA, LLC's trademark registration success rate?
ORLEGI USA, LLC has a 100% trademark registration rate, with 5 out of 5 resolved applications resulting in successful registration. Currently, 9 applications are pending review.